COMBATING HIV and HEPATITIS B
A symposium that addresses critical issues on the challenges of developinga
n HIV vaccine and ensuring the eradication of Hepatitis B
10 May 2007 / Room 119, Thomas Jefferson Building, Library of Congress
Combating HIV and Hepatitis B - Morning Session
Welcome - James H. Billington, Librarian of Congress
Baruch S. Blumberg, Nobel Laureate and Chairman of the
Kluge Center Advisory Board,
Library of Congress
"What can we learn about HIV from HBV research and applications that derived from it?"
Raymond Dwek, FRS, Kluge Chair of Technology and Society
9:30 A.M. - Session I: Development of an HIV Vaccine for prevention of AIDS - current global efforts and two principle scientific challenges
Gary Nabel, M.D., Ph.D., Director
Dale and Betty Bumpers Vaccine Research Center, National Institutes of Health
"Current Status of AIDS Vaccine Development"
Bruce Walker, M.D., Investigator
Howard Hughes Medical Institutes
"Scientific challenge: Vaccine design for control of HIV"
Dennis R. Burton, Ph.D. Professor
The Scripps Research Institute
"Scientific challenge: Vaccine design to elicit broadly neutralizing antibodies"
Seth Berkley, M.D., President and Founder
International AIDS Vaccine Initiative
"Future directions and innovations in AIDS vaccine development"
Summary - Seth Berkley
Combating HIV and Hepatitis B - Afternoon Session
1:00 P.M. - Session II: Hepatitis B and co-infection with HIV
Welcome and Introduction
Raymond Dwek, FRS, Kluge Chair of Technology and Society, Library of Congress
Baruch S. Blumberg, Nobel Laureate, Fox Chase Cancer
Center, Chair of Advisory Board, Kluge Center
"The nature of HBV and the first "cancer vaccine"
Timothy Block, Ph.D., President, Hepatitis B Foundation and Professor, Drexel University College of Medicine
David Thomas, M.D., Professor of Medicine,
Johns Hopkins University College of Medicine
"Problems associated with HIV and HBV co-infection"
Alison Evans, Sc.D., Director, Public Health Research,
Hepatitis B Foundation and Asst. Professor, Drexel University School
of Public Health
"Are the number of people in the U.S. infected with HBV greatly underestimated?"
John W. Ward, M.D., Director
Division of Viral Hepatitis, Centers for Disease Control and Prevention
"Challenges to eradication of HBV"
Paul Coleman, Ph.D., Research Fellow, Abbott Laboratories
"HBV envelope protein mutants as challenges to surveillance and immunization"
Drs. Block, Ward, Thomas, Evans, Blumberg, and Molli Conti, Executive Director, Hepatitis B Foundation
Statement of Findings, Baruch S. Blumberg